Measurement and clinical effect of grey matter pathology in multiple sclerosis

[1]  B. Serafini,et al.  Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain. , 2013, Brain : a journal of neurology.

[2]  Bernhard Hemmer,et al.  Potassium channel KIR4.1 as an immune target in multiple sclerosis. , 2012, The New England journal of medicine.

[3]  M. Calabrese,et al.  Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis , 2012, Multiple sclerosis.

[4]  T. Benner,et al.  Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH‐T2* , 2012, Journal of magnetic resonance imaging : JMRI.

[5]  M. Calabrese,et al.  The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing–remitting multiple sclerosis , 2012, Multiple sclerosis.

[6]  F. Barkhof,et al.  Postmortem verification of MS cortical lesion detection with 3D DIR , 2012, Neurology.

[7]  J. Lünemann.  Epstein-Barr virus in multiple sclerosis , 2012, Neurology.

[8]  A. Minagar.  Epstein–Barr virus in the multiple sclerosis brain: a controversial issue—report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria , 2012 .

[9]  P. Stys,et al.  Will the real multiple sclerosis please stand up? , 2012, Nature Reviews Neuroscience.

[10]  J. Geurts,et al.  Gray matter imaging in multiple sclerosis: what have we learned? , 2011, BMC neurology.

[11]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[12]  E. Fisher.  Multiple Sclerosis Therapeutics: Measurement of CNS atrophy , 2011 .

[13]  M. Battaglini,et al.  Cortical lesions in radiologically isolated syndrome , 2011, Neurology.

[14]  F. Barkhof,et al.  Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis , 2011, Multiple sclerosis.

[15]  P. Matthews,et al.  Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.

[16]  R. Reynolds,et al.  Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. , 2011, Brain : a journal of neurology.

[17]  H. Lassmann,et al.  Epstein–Barr virus in the multiple sclerosis brain: a controversial issue—report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria , 2011, Brain : a journal of neurology.

[18]  M. Calabrese,et al.  The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.

[19]  E. Aronica,et al.  Cholinergic imbalance in the multiple sclerosis hippocampus , 2011, Acta Neuropathologica.

[20]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[21]  J. Parisi,et al.  A case of multiple sclerosis presenting with inflammatory cortical demyelination , 2011, Neurology.

[22]  Ponnada A Narayana,et al.  Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis , 2011, Multiple sclerosis.

[23]  B. Trapp,et al.  Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients , 2011, Annals of neurology.

[24]  R Bakshi,et al.  Identification and Clinical Impact of Multiple Sclerosis Cortical Lesions as Assessed by Routine 3T MR Imaging , 2011, American Journal of Neuroradiology.

[25]  Richard Reynolds,et al.  Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis , 2011, Annals of neurology.

[26]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[27]  O. Ciccarelli,et al.  Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI , 2011, Neurology.

[28]  Robert Fox,et al.  CLADA: Cortical longitudinal atrophy detection algorithm , 2011, NeuroImage.

[29]  Robert Zivadinov,et al.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.

[30]  D. Louis Collins,et al.  Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.

[31]  C. Polman,et al.  Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging , 2010, Multiple sclerosis.

[32]  R. Kane,et al.  T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis , 2010, Multiple sclerosis.

[33]  David H. Miller,et al.  Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial , 2010, The Lancet Neurology.

[34]  J. Ranjeva,et al.  Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  Ludwig Kappos,et al.  Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis—A longitudinal MRI study , 2010, Brain Research.

[36]  David H. Miller,et al.  High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. , 2010, Brain : a journal of neurology.

[37]  M. Filippi,et al.  A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis , 2009, Annals of neurology.

[38]  V. Steen,et al.  Upregulation of Immunoglobulin‐related Genes in Cortical Sections from Multiple Sclerosis Patients , 2009, Brain pathology.

[39]  D. Hafler,et al.  Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. , 2009, Brain : a journal of neurology.

[40]  Caterina Mainero,et al.  In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI , 2009, Neurology.

[41]  Nicola De Stefano,et al.  Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS , 2009, Journal of the Neurological Sciences.

[42]  Massimo Filippi,et al.  Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. , 2009, Archives of neurology.

[43]  J. Geurts,et al.  Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis , 2009, Journal of neuropathology and experimental neurology.

[44]  M. Calabrese,et al.  Magnetic resonance evidence of cortical onset of multiple sclerosis , 2009, Multiple sclerosis.

[45]  Peter K. Stys,et al.  Gray matter pathology in (chronic) MS: Modern views on an early observation , 2009, Journal of the Neurological Sciences.

[46]  Robert Zivadinov,et al.  Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis A 5-year longitudinal study , 2009, Journal of the Neurological Sciences.

[47]  F. Barkhof,et al.  Accumulation of cortical lesions in MS: relation with cognitive impairment , 2009, Multiple sclerosis.

[48]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[49]  M. Filippi,et al.  Cortical lesions in primary progressive multiple sclerosis , 2009, Neurology.

[50]  Richard Nicholas,et al.  Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis , 2009, Brain pathology.

[51]  E. Portaccio,et al.  Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study , 2009, Multiple sclerosis.

[52]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[53]  Kunio Nakamura,et al.  Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients , 2009, NeuroImage.

[54]  Marco Battaglini,et al.  Brain atrophy assessment in multiple sclerosis: importance and limitations. , 2008, Neuroimaging clinics of North America.

[55]  D. Ramasamy,et al.  Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[56]  J. Lowe,et al.  Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[57]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[58]  David H. Miller,et al.  Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.

[59]  Frederik Barkhof,et al.  Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.

[60]  R. Henry,et al.  Regional grey matter atrophy in clinically isolated syndromes at presentation , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[61]  Frederik Barkhof,et al.  In vivo MR imaging of hippocampal lesions in multiple sclerosis , 2008, Journal of magnetic resonance imaging : JMRI.

[62]  Kyle C. Kern,et al.  Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.

[63]  F. Barkhof,et al.  Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? , 2008, Journal of Neurology.

[64]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[65]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[66]  P. Narayana,et al.  Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging , 2007, American Journal of Neuroradiology.

[67]  Frederik Barkhof,et al.  Extensive Hippocampal Demyelination in Multiple Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[68]  Marco Rovaris,et al.  MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study , 2007, The Lancet Neurology.

[69]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[70]  R. Mutani,et al.  Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage , 2007, Journal of neuropathology and experimental neurology.

[71]  H. D. de Vries,et al.  The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions , 2007, Journal of neuropathology and experimental neurology.

[72]  R. Zivadinov,et al.  I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy , 2007, Multiple sclerosis.

[73]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[74]  Frederik Barkhof,et al.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. , 2007, Archives of neurology.

[75]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[76]  J H Simon,et al.  Brain atrophy in multiple sclerosis: what we know and would like to know , 2006, Multiple sclerosis.

[77]  M Riva,et al.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. , 2006, AJNR. American journal of neuroradiology.

[78]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[79]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[80]  James Lowe,et al.  Spinal Cord Gray Matter Demyelination in Multiple Sclerosis—A Novel Pattern of Residual Plaque Morphology , 2006, Brain pathology.

[81]  Emilio Portaccio,et al.  Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies , 2006, Journal of the Neurological Sciences.

[82]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[83]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[84]  R. Bakshi,et al.  Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[85]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[86]  Rohit Bakshi,et al.  The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction , 2005, NeuroImage.

[87]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[88]  Mara Cercignani,et al.  Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.

[89]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[90]  L. Bö,et al.  The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.

[91]  D. Louis Collins,et al.  Relating neocortical pathology to disability progression in multiple sclerosis using MRI , 2004, NeuroImage.

[92]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[93]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[94]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[95]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[96]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[97]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[98]  Ralph H B Benedict,et al.  Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.

[99]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[100]  Alan J Thompson,et al.  The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodology , 2002, Journal of magnetic resonance imaging : JMRI.

[101]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[102]  W. Kamphorst,et al.  Hypothalamic Lesions in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[103]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[104]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[105]  P M Thompson,et al.  Unfolding the human hippocampus with high resolution structural and functional MRI , 2001, The Anatomical record.

[106]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[107]  A J Thompson,et al.  Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.

[108]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[109]  Jeffrey A. Cohen,et al.  Multiple Sclerosis Therapeutics , 1999 .

[110]  A A Bankier,et al.  Double inversion recovery imaging of the brain: initial experience and comparison with fluid attenuated inversion recovery imaging. , 1998, Magnetic resonance imaging.

[111]  J. Ashburner,et al.  Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.

[112]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[113]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[114]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.

[115]  F. Schob.  Ein Beitrag zur pathologischen Anatomie der multiplen Sklerose. , 1907 .